WallStreetZenWallStreetZen

NASDAQ: ESPR
Esperion Therapeutics Inc Stock Ownership - Who owns Esperion Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Esperion Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eric WarrenChief Commercial Officer2024-11-19197$2.17
$426.51Sell
Eric WarrenChief Commercial Officer2024-10-17107$2.12
$226.73Sell
Eric WarrenChief Commercial Officer2024-09-172,608$1.78
$4.65kSell
Sheldon L. KoenigPresident and CEO2024-09-1714,550$1.80
$26.13kSell
Eric WarrenChief Commercial Officer2024-08-19211$1.95
$410.61Sell
Eric WarrenChief Commercial Officer2024-07-17108$2.59
$279.40Sell
Joanne M. FoodyChief Medical Officer2024-07-17917$2.60
$2.38kSell
Joanne M. FoodyChief Medical Officer2024-06-183,285$2.87
$9.42kSell
Eric WarrenChief Commercial Officer2024-06-182,540$2.86
$7.25kSell
Eric WarrenChief Commercial Officer2024-05-17192$2.48
$476.74Sell

1 of 1

ESPR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ESPR insiders and whales buy or sell their stock.

ESPR Shareholders

What type of owners hold Esperion Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Wasatch Advisors LP11.85%23,346,013$77.98MInstitution
Blackrock Inc 17.24%14,264,975$47.65MInstitution
Vanguard Group Inc6.62%13,043,077$43.56MInstitution
Bellevue Group Ag5.05%9,944,064$33.21MInstitution
Two Seas Capital LP3.34%6,584,278$21.99MInstitution
Target N. V. Biotech2.27%4,477,964$14.96MInsider
Geode Capital Management LLC2.20%4,331,314$14.47MInstitution
Alta Partners VIII LP2.16%4,262,156$14.24MInsider
State Street Corp1.96%3,854,314$12.87MInstitution
Meditor Group Ltd1.92%3,791,300$12.66MInstitution

1 of 3

ESPR vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ESPR65.61%20.00%Net SellingNet Selling
BIOA57.66%24.77%Net BuyingNet Buying
CRON10.89%48.36%Net Selling
EOLS73.92%26.08%Net Selling
IRWD71.93%28.07%Net SellingNet Selling
View Top Pharmaceutical Stocks

Esperion Therapeutics Stock Ownership FAQ

Who owns Esperion Therapeutics?

Esperion Therapeutics (NASDAQ: ESPR) is owned by 65.61% institutional shareholders, 20.00% Esperion Therapeutics insiders, and 14.40% retail investors. Target N. V. Biotech is the largest individual Esperion Therapeutics shareholder, owning 4.48M shares representing 2.27% of the company. Target N. V. Biotech's Esperion Therapeutics shares are currently valued at $15.58M.

If you're new to stock investing, here's how to buy Esperion Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.